X4 Pharmaceuticals secures up to $150 mln term loan
X4 Pharmaceuticals entered a secured term loan facility of up to $150 million with K2 HealthVentures, funding $80 million at closing to refinance existing debt and support operations and growth.
X4 Pharmaceuticals entered a secured term loan facility of up to $150 million with K2 HealthVentures, funding $80 million at closing to refinance existing debt and support operations and growth.